Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 25-36 of 4,306
Biological study icon
RecruitingNCT04226898

Synbiotic Compound to Reduce Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Batlimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT07445620

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms for schizophrenia

This study is not yet recruiting in India. It is testing Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms for schizophrenia.

In Bhubaneswar
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Schizophrenia
Device study icon
RecruitingNCT06911931

Visual Perception in Schizophrenia

This study is looking at identify novel markers of psychosis using electroencephalography (EEG) for people with Schizophrenia Disorders, bipolarity, or Schizo Affective Disorder. Taking part may give some people access to EEG measure of visual processing, but direct benefit is not guaranteed.

In Rochester
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Rochester
Condition
Schizophrenia, Bipolarity
Other study type icon
RecruitingNCT06740383

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hartford
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 40 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia, Bipolarity
Other study type icon
RecruitingNCT06431009

The Danish Region Midt Schizophrenia Cohort

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aarhus
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalOver 15 Years
Countries
Denmark
Sponsor
University of Aarhus
Condition
Schizophrenia
Behavioral study icon
Not Yet RecruitingNCT06974513

Auditory Localization in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Bron
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
France
Sponsor
Hôpital le Vinatier
Condition
Schizophrenia
Drug study icon
RecruitingISRCTN59554792

The efficacy of xanomeline-trospium in treating cognitive impairment in people with a psychotic disorder

This study is testing a medication approach for people with Schizophrenia, schizoaffective disorder, or schizophreniform disorder or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.